Confirmatory Evidence: Related Indication Must Have A Completed Study That Established Benefit, US FDA Says

At the advisory committee review of Stealth’s Barth syndrome treatment elamipretide, Office of New Drugs Director Peter Stein clarified the circumstances where clinical data in a related indication could serve as confirmatory evidence for a single adequate and well-controlled study.